OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores
Julian R. Homburger, Cynthia L. Neben, Gilad Mishne, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Akl C. Fahed, Minxian Wang, Julian R. Homburger, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 355

Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Jack W. O’Sullivan, Sridharan Raghavan, Carla Márquez‐Luna, et al.
Circulation (2022) Vol. 146, Iss. 8
Open Access | Times Cited: 245

Development of a clinical polygenic risk score assay and reporting workflow
Limin Hao, Peter Kraft, Gabriel F. Berriz, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1006-1013
Open Access | Times Cited: 134

Clinical utility of polygenic risk scores for coronary artery disease
Derek Klarin, Pradeep Natarajan
Nature Reviews Cardiology (2021) Vol. 19, Iss. 5, pp. 291-301
Open Access | Times Cited: 110

Recent advances in polygenic scores: translation, equitability, methods and FAIR tools
Ruidong Xiang, Martin Kelemen, Yu Xu, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 29

Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays
Jeremiah H. Li, Chase A. Mazur, Tomaz Berisa, et al.
Genome Research (2021) Vol. 31, Iss. 4, pp. 529-537
Open Access | Times Cited: 95

Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians
Minxian Wang, Ramesh Menon, Sanghamitra Mishra, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 6, pp. 703-714
Open Access | Times Cited: 93

Evaluating genotype imputation pipeline for ultra-low coverage ancient genomes
Ruoyun Hui, Eugenia D’Atanasio, Lara M. Cassidy, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 83

Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populations
Alicia R. Martin, Elizabeth G. Atkinson, Sinéad B. Chapman, et al.
The American Journal of Human Genetics (2021) Vol. 108, Iss. 4, pp. 656-668
Open Access | Times Cited: 72

Reconstruction of the personal information from human genome reads in gut metagenome sequencing data
Yoshihiko Tomofuji, Kyuto Sonehara, Toshihiro Kishikawa, et al.
Nature Microbiology (2023) Vol. 8, Iss. 6, pp. 1079-1094
Open Access | Times Cited: 23

Genetic testing in cardiovascular disease
Michael P. Gray, Diane Fatkin, Jodie Ingles, et al.
The Medical Journal of Australia (2024) Vol. 220, Iss. 8, pp. 428-434
Open Access | Times Cited: 11

Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes
Wataru Nakamura, Makoto Hirata, Satoyo Oda, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10

The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 369-377
Closed Access | Times Cited: 8

Design and user experience testing of a polygenic score report: a qualitative study of prospective users
Deanna Brockman, L Petronio, Jacqueline S. Dron, et al.
BMC Medical Genomics (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 44

Polygenic risk scores for the prediction of cardiometabolic disease
Jack W. O’Sullivan, Euan A. Ashley, Perry Elliott
European Heart Journal (2022) Vol. 44, Iss. 2, pp. 89-99
Closed Access | Times Cited: 37

Stability of polygenic scores across discovery genome-wide association studies
Laura M. Schultz, Alison Merikangas, Kosha Ruparel, et al.
Human Genetics and Genomics Advances (2022) Vol. 3, Iss. 2, pp. 100091-100091
Open Access | Times Cited: 31

Genotype imputation and variability in polygenic risk score estimation
Shang‐Fu Chen, Raquel Dias, D. Gareth Evans, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 42

Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery Disease
Dimitri J. Maamari, Deanna Brockman, Krishna G. Aragam, et al.
JACC Advances (2022) Vol. 1, Iss. 3, pp. 100068-100068
Open Access | Times Cited: 26

Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Honey V. Reddi, Hannah Wand, Birgit Funke, et al.
Genetics in Medicine (2023) Vol. 25, Iss. 5, pp. 100804-100804
Open Access | Times Cited: 14

A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome
Claude Bhérer, Robert Eveleigh, Katerina Trajanoska, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
D. Gareth Evans, Elke M. van Veen, Helen Byers, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 1, pp. 73-79
Open Access | Times Cited: 32

Constructing germline research cohorts from the discarded reads of clinical tumor sequences
Alexander Gusev, Stefan Groha, Kodi Taraszka, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 31

Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer
Elaine Tan, Todd C. Knepper, Xuefeng Wang, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2223-2223
Open Access | Times Cited: 21

Page 1 - Next Page

Scroll to top